Helix BioPharma(OTC) HBPCF

Market Cap$130.61M

Since IPO (2010)-87%

5 Year-51%

1 Year+185%

1 Month+0%

$1.71

+0.00%

+0.00Today

Helix BioPharma last closing stock price
Metric	Price	Date
Last close	USD 1.71	2026-08-03

Helix BioPharma stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+0%	USD 1.71	2026-07-02
1 month	+0%	USD 1.71	2026-07-02
3 month	-1.16%	USD 1.73	2026-04-22
Year to date	-1.37%	USD 1.73	2025-12-12
1 year	+185%	USD 0.60	2025-06-12
3 year	+135.86%	USD 0.73	2023-05-17
5 year	-51.49%	USD 3.53	2021-08-04
Since inception	-87.24%	USD 13.40	2010-09-24

Helix BioPharma Financials at a Glance

Market Cap

$130.61M

Revenue (TTM)

CA$0.00

Net Income (TTM)

-CA$3.37M

EPS (TTM)

-$0.03

P/E Ratio

-53.61

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$1.71

Volume

Open

$1.71

Price

$1.71

Volume

Open

$1.71

Previous Close

$1.71

Daily Range

$1.71 - $1.71

52-Week Range

$0.60 - $1.73

Estimated Earnings Date

Oct 29, 2026

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$1.71

Volume

Open

$1.71

Previous Close

$1.71

Daily Range

$1.71 - $1.71

52-Week Range

$0.60 - $1.73

Estimated Earnings Date

Oct 29, 2026

HBPCF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Helix BioPharma

Helix BioPharma Corp. is an immuno-oncology company, which engages in the development of products for the treatment and prevention of cancer. The company was founded on July 31, 1995 and is headquartered in Toronto, Canada.

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Thomas Mehrling, MD, PhD

Website

www.helixbiopharma.com

Headquarters

Toronto, ON M5H 2Y4, CA

HBPCF Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-21.54%

Return on Capital

-31.58%

Return on Assets

-15.54%

Earnings Yield

-1.87%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$130.61M

Shares Outstanding

76.38M

Volume

Avg. Volume

18.095

Financials (TTM)

Gross Profit

-CA$4.15K

Operating Income

-CA$3.32M

EBITDA

-CA$1.71M

Operating Cash Flow

-CA$3.21M

Capital Expenditure

CA$0.00

Free Cash Flow

-CA$3.21M

Cash & ST Invst.

CA$2.84M

Total Debt

CA$358.88K

Helix BioPharma Performance Analysis

Helix BioPharma annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-07-31	CAD 0	N/A
2023	2023-07-31	CAD 0	N/A
2024	2024-07-31	CAD 0	N/A
2025	2025-07-31	CAD 0	N/A

Helix BioPharma sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2025-07-31	N/A
Q1	2025-10-31	N/A
Q2	2026-01-31	N/A
Q3	2026-04-30	N/A

Helix BioPharma annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-07-31	CAD -0.17	N/A
2023	2023-07-31	CAD -0.12	-29.8%
2024	2024-07-31	CAD -0.15	26.3%
2025	2025-07-31	CAD -0.07	-56.3%

Helix BioPharma sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2025-07-31	94.2%
Q1	2025-10-31	-44.6%
Q2	2026-01-31	31.6%
Q3	2026-04-30	3.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2026YOY CHG

Revenue

CA$0.00

N/A

Gross Profit

-CA$999.00

+54.0%

Gross Margin

0.00%

N/A

Market Cap

$130.61M

N/A

Market Cap/Employee

$18.66M

N/A

Employees

N/A

Net Income

-CA$670.78K

+56.6%

EBITDA

-CA$688.77K

+55.3%

Quarterly Fundamentals

Name

Q3 2026YOY CHG

Total Cash

CA$2.84M

+297.4%

Total Debt

CA$358.88K

N/A

Accounts Receivable

CA$27.99K

-90.2%

Inventory

CA$0.00

N/A

Long Term Debt

CA$0.00

N/A

Short Term Debt

CA$358.88K

N/A

Return on Assets

-15.54%

N/A

Return on Invested Capital

-22.47%

N/A

Free Cash Flow

-CA$879.71K

+36.3%

Operating Cash Flow

-CA$879.71K

+36.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

INNMFAmplia Therapeutics Limited

INNMFAmplia Therapeutics Limited$0.11+4.09%

ACHFFArch Biopartners Inc.

ACHFFArch Biopartners Inc.$0.76-7.62%

VICPVicapsys Life Sciences, Inc.

VICPVicapsys Life Sciences, Inc.$1.45+0.00%

OTLCOncotelic Therapeutics, Inc.

OTLCOncotelic Therapeutics, Inc.$0.04-5.05%

ZIVOZIVO Bioscience, Inc.

ZIVOZIVO Bioscience, Inc.$4.05-5.62%

RLFTFMindMaze Therapeutics Holding S.A.

RLFTFMindMaze Therapeutics Holding S.A.$0.32+13.94%

TCNAFTransCanna Holdings Inc.

TCNAFTransCanna Holdings Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$8.61-0.02%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$146.23+0.04%

IPSTIp Strategy

IPSTIp Strategy$7.39+2.36%

NVDANvidia

NVDANvidia$225.01-0.00%

NOKNokia

NOKNokia$10.78+0.00%

INTCIntel

INTCIntel$103.49+0.01%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$8.69+0.02%

Questions About HBPCF

What is the current price of Helix BioPharma?

Helix BioPharma is trading at $1.71 per share.

What is the 52-week range for Helix BioPharma?

Over the past 52 weeks, Helix BioPharma has traded between $0.60 and $1.73.

How much debt does Helix BioPharma have?

As of the most recent reporting period, Helix BioPharma reported total debt of CA$263.76K.

How much cash does Helix BioPharma have on hand?

Helix BioPharma reported CA$2.09M in cash and cash equivalents in its most recent financial results.

What is Helix BioPharma’s dividend yield?

Helix BioPharma does not currently have a dividend yield.

Helix BioPharma(OTC) HBPCF

Helix BioPharma Financials at a Glance

HBPCF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Helix BioPharma

HBPCF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Helix BioPharma Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About HBPCF

What is the current price of Helix BioPharma?

What is the 52-week range for Helix BioPharma?

How much debt does Helix BioPharma have?

How much cash does Helix BioPharma have on hand?

What is Helix BioPharma’s dividend yield?

Premium Investing Services